Health Care Roundup: Market Talk
Find insight on Monash IVF and GSK in the latest Market Talks covering Health Care.
Read MoreGSK reports promising early results in ovarian and womb cancer drug trial
Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drugGSK has revealed positive results for a treatment for gynaecological cancers as its chief executive, Luke Miels, seeks to speed up drug development at the group.The company said that in an early-stage trial Mocertatug Rezetecan, known as Mo-Rez,…
Read MoreGSK withdrew an application for a drug touted by Trump and RFK Jr. as a potential treatment for autism
Generic versions of the drug will still be available to treat a rare genetic condition.
Read MorePipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn
UK’s GSK is leading the way in research but AstraZeneca is not involved in the area, report findsThe pipeline of new drugs to fight superbugs remains “worryingly thin” and has shrunk by 35% in the last five years, experts have said, predicting the annual number of deaths linked to drug-resistant infections globally will double to…
Read MoreGSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 Million
Under the deal, Alfasigma will gain rights to develop, manufacture and commercialize linerixibat.
Read More